Intra-fractional patient motion when using the Qfix Encompass immobilization system during HyperArc treatment of patients with brain metastases.

HyperArc QFix EncompassTM immobilization system intra-fractional patient motion stereotactic radiosurgery stereotactic radiotherapy

Journal

Journal of applied clinical medical physics
ISSN: 1526-9914
Titre abrégé: J Appl Clin Med Phys
Pays: United States
ID NLM: 101089176

Informations de publication

Date de publication:
Mar 2021
Historique:
revised: 28 11 2020
received: 02 06 2020
accepted: 04 12 2020
pubmed: 4 3 2021
medline: 22 6 2021
entrez: 3 3 2021
Statut: ppublish

Résumé

This study investigated the intra-fractional motion (IM) of patients immobilized using the QFix Encompass Immobilization System during HyperArc (HA) treatment. HA treatment was performed on 89 patients immobilized using the Encompass. The IM during treatment (including megavoltage (MV) registration) was analyzed for six degrees of freedom including three axes of translation (anterior-posterior, superior-inferior (SI) and left-right (LR)) and three axes of rotation (pitch, roll, and yaw). Then, the no corrected IM (IM The average IM in terms of the absolute displacement were 0.3 mm (SI), 0.3 mm (LR) and 0.2° (yaw) for Stereotactic radiosurgery (SRS), and 0.3 mm (SI), 0.2 mm (LR), and 0.2° (yaw) for stereotactic radiotherapy (SRT). The absolute maximum values of IM were <1 mm along the SI and LR axes and <1° along the yaw axis. The absolute maximum displacements for IM Encompass provided patient immobilization with adequate accuracy during HA treatment. The absolute maximum displacement IM was less than IM

Identifiants

pubmed: 33656261
doi: 10.1002/acm2.13143
pmc: PMC7984469
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

254-260

Subventions

Organisme : JSPS KAKENHI
ID : 19K17285

Informations de copyright

© 2021 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of American Association of Physicists in Medicine.

Références

Radiat Oncol. 2011 Nov 16;6:158
pubmed: 22085700
Med Dosim. 2016 Summer;41(2):173-9
pubmed: 26994827
Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):100-8
pubmed: 25442342
Strahlenther Onkol. 2014 Jun;190(6):521-32
pubmed: 24715242
Med Phys. 2008 Mar;35(3):1087-93
pubmed: 18404943
Technol Cancer Res Treat. 2017 Jun;16(3):321-331
pubmed: 27582369
J Appl Clin Med Phys. 2018 Jul;19(4):222-229
pubmed: 29905000
Radiother Oncol. 2010 Apr;95(1):109-15
pubmed: 20116123
Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):540-6
pubmed: 26460996
J Clin Oncol. 2015 Oct 20;33(30):3475-84
pubmed: 26282648
Int J Radiat Oncol Biol Phys. 1988 Feb;14(2):373-81
pubmed: 3276655
Pract Radiat Oncol. 2012 Oct-Dec;2(4):306-313
pubmed: 24674169
J Clin Oncol. 2011 Jan 10;29(2):134-41
pubmed: 21041710
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):37-46
pubmed: 16111570
J Appl Clin Med Phys. 2019 Oct;20(10):84-91
pubmed: 31507075
J Appl Clin Med Phys. 2018 May;19(3):58-63
pubmed: 29577592
Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1091-1098
pubmed: 30959122
Radiat Oncol. 2018 Jan 29;13(1):13
pubmed: 29378610

Auteurs

Riho Komiyama (R)

Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.

Shingo Ohira (S)

Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.
Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, Suita, Japan.

Hikari Ueda (H)

Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.

Naoyuki Kanayama (N)

Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.

Akira Masaoka (A)

Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.

Masaru Isono (M)

Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.

Yoshihiro Ueda (Y)

Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.

Masayoshi Miyazaki (M)

Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.

Teruki Teshima (T)

Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH